ICAM1 and non-small cell lung carcinoma: ICAM-1 is constitutively expressed at low levels in various cell types, including fibroblasts, endothelial cells, and leukocytes, pathologically expressed in NSCLC tumors at higher levels that correlate positively with those of soluble lCAM-1 in serum, and associated with metastatic disease33.